# Nature Reviews Clinical Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/nature-reviews-clinical-oncology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 301,910 |
| h-index | 285 |
| Homepage | http://www.nature.com/nrclinonc |
| Open Access | false |
| ISSN-L | 1759-4774 |
| ISSNs | 1759-4774,1759-4782 |
| OpenAlex ID | https://openalex.org/S41981144 |
| Publisher | Nature Portfolio |
| Works | 3,371 |

## Journal papers

Showing 12 of 23.

- [Radiomics: the bridge between medical imaging and personalized medicine](https://scholariq.org/papers/radiomics-the-bridge-between-medical-imaging-and-personalized-medicine/)
- [Tumour heterogeneity and resistance to cancer therapies](https://scholariq.org/papers/tumour-heterogeneity-and-resistance-to-cancer-therapies/)
- [PD-L1 as a biomarker of response to immune-checkpoint inhibitors](https://scholariq.org/papers/pd-l1-as-a-biomarker-of-response-to-immune-checkpoint-inhibitors/)
- [Monitoring immune-checkpoint blockade: response evaluation and biomarker development](https://scholariq.org/papers/monitoring-immune-checkpoint-blockade-response-evaluation-and-biomarker/)
- [Advancing therapy for osteosarcoma](https://scholariq.org/papers/advancing-therapy-for-osteosarcoma/)
- [Src kinases as therapeutic targets for cancer](https://scholariq.org/papers/src-kinases-as-therapeutic-targets-for-cancer/)
- [Lineage plasticity in cancer: a shared pathway of therapeutic resistance](https://scholariq.org/papers/lineage-plasticity-in-cancer-a-shared-pathway-of-therapeutic-resistance/)
- [Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours](https://scholariq.org/papers/overcoming-on-target-off-tumour-toxicity-of-car-t-cell-therapy-for-solid-tumours/)
- [Personalized early detection and prevention of breast cancer: ENVISION consensus statement](https://scholariq.org/papers/personalized-early-detection-and-prevention-of-breast-cancer-envision-consensus/)
- [Predicting outcomes in radiation oncology—multifactorial decision support systems](https://scholariq.org/papers/predicting-outcomes-in-radiation-oncology-multifactorial-decision-support/)
- [Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer](https://scholariq.org/papers/evolution-of-systemic-therapy-for-stages-i-iii-non-metastatic-non-small-cell/)
- [Radiotheranostics in oncology: current challenges and emerging opportunities](https://scholariq.org/papers/radiotheranostics-in-oncology-current-challenges-and-emerging-opportunities/)

## Journal top topics

Showing 8 of 25.

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.